ZA931099B - Heterocyclic compounds their use and preparation - Google Patents

Heterocyclic compounds their use and preparation

Info

Publication number
ZA931099B
ZA931099B ZA931099A ZA931099A ZA931099B ZA 931099 B ZA931099 B ZA 931099B ZA 931099 A ZA931099 A ZA 931099A ZA 931099 A ZA931099 A ZA 931099A ZA 931099 B ZA931099 B ZA 931099B
Authority
ZA
South Africa
Prior art keywords
preparation
heterocyclic compounds
compounds
benzazepines
tetrahydro
Prior art date
Application number
ZA931099A
Other languages
English (en)
Inventor
Christian Foged
Rolf Hohlweg
Erik Bardrum Nielsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA931099B publication Critical patent/ZA931099B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA931099A 1992-02-24 1993-02-17 Heterocyclic compounds their use and preparation ZA931099B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK92233A DK23392D0 (da) 1992-02-24 1992-02-24 Heterocykliske forbindelser, deres anvendelse og fremstilling

Publications (1)

Publication Number Publication Date
ZA931099B true ZA931099B (en) 1994-08-17

Family

ID=8091236

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931099A ZA931099B (en) 1992-02-24 1993-02-17 Heterocyclic compounds their use and preparation

Country Status (23)

Country Link
EP (1) EP0628039B1 (cs)
JP (1) JPH07504172A (cs)
KR (1) KR100255739B1 (cs)
AT (1) ATE152450T1 (cs)
AU (1) AU667878B2 (cs)
BG (1) BG62208B1 (cs)
CA (1) CA2130678C (cs)
CZ (1) CZ288626B6 (cs)
DE (1) DE69310353T2 (cs)
DK (2) DK23392D0 (cs)
ES (1) ES2102019T3 (cs)
FI (1) FI113770B (cs)
GR (1) GR3023896T3 (cs)
HU (1) HU221314B1 (cs)
IL (1) IL104657A (cs)
NO (1) NO310193B1 (cs)
NZ (1) NZ249465A (cs)
RO (1) RO116088B1 (cs)
RU (1) RU2114839C1 (cs)
SK (1) SK281390B6 (cs)
UA (1) UA34451C2 (cs)
WO (1) WO1993017012A1 (cs)
ZA (1) ZA931099B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0750616B1 (en) * 1994-03-16 2001-05-30 CeNeS Limited Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
KR19990044648A (ko) * 1995-09-15 1999-06-25 한센 핀 베네드, 안네 제헤르 2,3,4,5-테트라히드로-1h-3-벤즈아제핀 화합물의 산 부가염
GB0130576D0 (en) * 2001-12-20 2002-02-06 Cenes Ltd Dopamine D1 receptor agonist pro-drug compounds & derivatives
JP4584831B2 (ja) * 2002-12-20 2010-11-24 グラクソ グループ リミテッド 神経系の疾患の治療用のベンズアゼピン誘導体
PL2912019T3 (pl) 2012-10-25 2021-11-02 Tetra Discovery Partners Llc Heteroarylowe inhibitory pde4
WO2015048407A1 (en) * 2013-09-26 2015-04-02 Tetra Discovery Partners, LLC Heteroaryl inhibitors of pde4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
DK325188D0 (da) * 1988-06-15 1988-06-15 Novo Industri As Hidtil ukendte benzazepinderivater
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater

Also Published As

Publication number Publication date
CA2130678A1 (en) 1993-08-25
DE69310353T2 (de) 1997-10-02
DK23392D0 (da) 1992-02-24
FI943875A0 (fi) 1994-08-23
NO943123D0 (no) 1994-08-24
NO310193B1 (no) 2001-06-05
KR950700286A (ko) 1995-01-16
DE69310353D1 (de) 1997-06-05
EP0628039B1 (en) 1997-05-02
IL104657A (en) 1999-11-30
UA34451C2 (uk) 2001-03-15
GR3023896T3 (en) 1997-09-30
JPH07504172A (ja) 1995-05-11
HU9402434D0 (en) 1994-10-28
CA2130678C (en) 2004-04-20
FI113770B (fi) 2004-06-15
NZ249465A (en) 1996-02-27
AU3626593A (en) 1993-09-13
FI943875L (fi) 1994-08-23
SK100094A3 (en) 1995-04-12
RU2114839C1 (ru) 1998-07-10
ES2102019T3 (es) 1997-07-16
CZ288626B6 (cs) 2001-08-15
AU667878B2 (en) 1996-04-18
KR100255739B1 (ko) 2000-05-01
WO1993017012A1 (en) 1993-09-02
DK0628039T3 (da) 1997-12-08
BG62208B1 (bg) 1999-05-31
ATE152450T1 (de) 1997-05-15
SK281390B6 (sk) 2001-03-12
EP0628039A1 (en) 1994-12-14
IL104657A0 (en) 1993-06-10
HUT71127A (en) 1995-11-28
NO943123L (no) 1994-08-24
BG98993A (bg) 1995-05-31
RU94040719A (ru) 1996-07-10
HU221314B1 (en) 2002-09-28
CZ198894A3 (en) 1995-10-18
RO116088B1 (ro) 2000-10-30

Similar Documents

Publication Publication Date Title
KR100246065B1 (en) Substituted 3-aminoquinuclidines
IL119461A (en) 4,7-disubstituted -7H-pyrrolo ¬2, 3-d¾pyrimidines
NL300078I1 (nl) Farmaceutische verbindingen.
GB9514473D0 (en) Chemical compounds
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
ATE50763T1 (de) Tetralin-derivate, ihre herstellung und verwendung.
GR3021411T3 (en) Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles.
NO990542D0 (no) K-252a-derivater og anvendelse av K-252a-derivater
IL110204A0 (en) Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disorders
ATE206708T1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
ATE53377T1 (de) 1-substituierte tetralinderivate, ihre herstellung und verwendung.
FI970469A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
ZA931099B (en) Heterocyclic compounds their use and preparation
ATE39694T1 (de) (pyrrol-1-yl)-phenyl-dihydropyridazinone, ihre herstellung und verwendung.